Harvey Levy
Clinical Biochemical Genetics · Boston, MANPI 1972593150
Payments from drug & device makers
Across 107 payments — averaging $17,971 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$1.4M
- Biomarin Pharmaceutical Inc.$485K
- Sanofi US Services Inc.$16K
- PTC Therapeutics, Inc.$13K
- Agios Pharmaceuticals, Inc.$6K
- Amicus Therapeutics, Inc.$700
What the payments were for
- Consulting fees$41,35785%
- Travel & lodging$4,2449%
- Food & beverage$7902%
- Education$2,3015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 46 | $1,402,117 |
| Biomarin Pharmaceutical Inc. | 34 | $485,245 |
| Sanofi US Services Inc. | 5 | $16,272 |
| PTC Therapeutics, Inc. | 18 | $12,672 |
| Agios Pharmaceuticals, Inc. | 3 | $5,909 |
| Amicus Therapeutics, Inc. | 1 | $700 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical biochemical genetics providers in Massachusettsto place this figure against a meaningful peer group, so we don't.
Other clinical biochemical genetics in Boston
- Gerard BerryBoston$110K
- Deborah MarsdenBoston$2K
- Inderneel SahaiJamaica Plain$42
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.